Industry
| Exhibition |
Collapse/Expand
| Space # | Company |
| 101 | GW Pharmaceuticals part of Jazz Pharmaceuticals |
| 102 | Angelini Pharma |
| 103 | LivaNova |
| 201 | UCB |
| 301 | Eisai |
| 302 | Desitin Pharma GmbH |
| 303 | Takeda |
| 313 | Neuro Event Labs |
| 304 | UNEEG medical |
| 305 | BIOCODEX |
| 306 | Nutricia |
| 402 | Brainlab |
| 403 | AIT (Austrian Institute of Technology) |
| 405 | vCreate |
| 406 | Micromed Group |
| 407 | JOHN LIBBEYEUROTEXT |
| 408 | Ad-Tech Medical Instrument Corporation |
| 409 | Deep Breath Intelligence AG |
| 410 | Compumedics Ltd. |
| 501 | Nihon Kohden Europe |
| 502 | DIXI medical |
| 601 | ILAE YES |
| 602 | Persyst Development Corporation |
| 604 | Medtronic |
| 605 | Seer |
| 701 | PTC Therapeutics |
| 702 | Stoke Therapeutics |
| 703 | Ripple |
| 801 | Epilog |
| 802 | BESA |
| 803 | Neuroventis |
| 805 | Natus |
| 806 | NightWatch |
| T1 | Anita Kaufmann Foundation |
| T2 | EpiCare |
| T3 | Swiss League Against Epilepsy |
| T4 | Epi Suisse |
| T5 | Dravet Syndrome European Foundation |
Exhibition Opening Hours
|
9 July |
14:00-18:00 |
|
10 July |
09:00-16:40 |
|
11 July |
09:00-16:40 |
|
12 July |
09:00-16:40 |
|
13 July |
09:00-12:00 |
| Sponsors |
Collapse/Expand
| Major Partner | Partners | |||
part of Jazz Pharmaceuticals |
|
|
| Supporters | ||||||
|
|
|
 |
| Contributors | ||||||
|
|
|
| Patrons | ||||||||
|
|
|
|
|
||||
 |
|
|
|
|
||||
|
|
|
|
|
||||
|
|
|
|
|
| Satellite Symposia |
| Time & Date | 16:30-18:00, Saturday, 9 July 2022 |
| Location | Room W |
| Chair | Lieven Lagae (Belgium) |
| Presentation 1 | Annamaria Vezzani (Italy): Why do some patients become pharmacoresistant? What we know and open questions. |
| Presentation 2 | Fabrice Batolomei (France): What can functional connectivity tell us about effects of VNS? |
| Presentation 3 | Lieven Lagae (Belgium): Beyond seizure progression: mechanisms of cognitive and behavioral impairment in epileptic encephalopathies. |
| Time & Date | 16:30-18:00, Saturday, 9 July 2022 |
| Location | Room V |
| Speakers | Renzo Guerrini (Italy) & Nicola Specchio (Italy) |
| Time & Date | 08:00-09:30, Sunday, 10 July 2022 |
| Location | Room X |
| Chairs | Caroline Neuray (Belgium) & Marie Terrill (USA) |
| Presentation 1 | Margitta Seeck (Switzerland): Role of ESI in adults |
| Presentation 2 | Elliott Warren (UK): Use of ESI in paediatric population |
| Presentation 3 | Vadym Gnakovsky (Germany): The added value of ESI |
| Presentation 4 | Pieter van Mierlo (Belgium) & Marie Terill (USA): Case-based workshop |
| Time & Date | 13:45-15:00, Sunday, 10 July 2022 |
| Location | Room W |
| Chair | Christoph Hertzberg (Germany) |
| Presentation 1 | Nicola Specchio (Italy) |
| Presentation 2 | Stéphane Auvin (France) |
| Presentation 3 | Patricia Smeyers (Spain) |
This promotional session is intended for a healthcare professional or prescriber audience only and is organised and funded by GW Pharmaceuticals, part of Jazz Pharmaceuticals.GW/Jazz product(s) will be discussed during this session. GW/Jazz product informationis in line with the EMA product licence. International prescribing informationand adverse event reporting informationwill be available at this session,and both International and Swiss prescribing information will be available at the GW/Jazz exhibition booth. The indication may differ in your country; please refer to local prescribing information.
| Time & Date | 16:45-18:15, Sunday, 10 July 2022 |
| Location | Room W |
| Chair | Margitta Seeck (Switzerland) |
| Presentation 1 | Margitta Seeck (Switzerland): Introduction & clinical cases |
| Presentation 2 | Adam Strzelczyk (Germany): Management of elderly patients with epilepsy |
| Presentation 3 | Simona Lattanzi (Italy): Pharmacological treatment of epilepsy in elderly: clinical insights |
| Time & Date | 08:00-09:30, Monday, 11 July 2022 |
| Location | Room W |
| Chair | Francesco Porta (Italy) |
| Presentation 1 | Bruria Ben-Zeev (Israel): Identifying AADC deficiency – an underdiagnosed and underreported neurometabolic disorder |
| Presentation 2 | Francesco Porta (Italy): Therapeutic landscape for AADC deficiency: Key clinical data and patient outcomes |
| Presentation 3 | Richard Poulin (USA): The AADC deficiency patient journey: A caregiver’s perspective |
| Time & Date | 13:45-15:00, Monday, 11 July 2022 |
| Location | Room W |
| Chair | John Paul Leach (UK) |
| Presentation 1 | Ley Sander (UK): Towards seizure freedom: getting the best of Antiseizure medications |
| Presentation 2 | John Paul Leach (UK): An overview of the key clinical trial data for cenobamate |
| First Debate | From clinical evidence to real world experience |
| Second Debate | Where now for ASM Clinical Trials? |
| Panel | Bettina Schmitz (Germany), Vicente Villanueva (Spain), Ley Sander (UK) |
| Time & Date | 16:45-18:15, Monday, 11 July 2022 |
| Location | Room W |
| Chair | Adam Strzelczyk (Germany) |
| Presentation 1 | Rima Nabbout (France) |
| Presentation 2 | Carlo Di Bonaventura (Italy) |
| Presentation 3 | Shanika Samarasekera (UK) |
This promotional session is intended for a healthcare professional or prescriber audience only and is organised and funded by GW Pharmaceuticals, part of Jazz Pharmaceuticals.GW/Jazz product(s) will be discussed during this session. GW/Jazz product informationis in line with the EMA product licence. International prescribing informationand adverse event reporting informationwill be available at this session,and both International and Swiss prescribing information will be available at the GW/Jazz exhibition booth. The indication may differ in your country; please refer to local prescribing information.
| Time & Date | 13:45-15:00, Tuesday, 12 July 2022 |
| Location | Room W |
| Chair | Rima Nabbout (France) |
| Presentation 1 | Rima Nabbout (France): The Importance of Non-Seizure Outcomes in DEEs: An Overview |
| Presentation 2 | Renzo Guerrini (Italy): Improving Non-Seizure Outcomes in DEEs with Targeted Therapies |
| Presentation 3 | Jeffrey Noebels (USA): Effect of Targeted Therapies on SUDEP Mortality: An Update |
| Time & Date | 16:45-18:15, Tuesday, 12 July 2022 |
| Location | Room W |
| Chair | Bernhard Steinhoff (Germany) |
| Presentation 1 | Eva Theochari (UK): Switching between monotherapies or adding another antiseizure medication? A case supporting rational polytherapy |
| Presentation 2 | Angelo Labate (Italy): iCases, clinical experience of early add on adjunctive anti-seizure medication |
Sándor Beniczky (Denmark)
Pierre Mégevand (Switzerland)
Stefan Rampp (Germany)
Part 1 (Theory) Monday, 11 July 2022, 08:00-09:30, Room V
Part 2 (Hands-On) Tuesday, 12 July 2022, 08:00-09:30, Room W
Please note: Part 2 (Hands-On) requires a registration add-on to participate. No spaces are available. Participants can avail of the free trial software installation which should be installed on their deivce prior to Tuesday, 12 July at space #802 in the exhibition area.
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community